Interleukin-6 restricts pre-thymic T cell lineage commitment of progenitors driving loss of SIV control.
Saved in:
| Title: | Interleukin-6 restricts pre-thymic T cell lineage commitment of progenitors driving loss of SIV control. |
|---|---|
| Authors: | Anwar S; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.; Division of Microbiology and Immunology, Emory Vaccine Centre, Emory National Primate Research Centre, Emory University, Atlanta, Georgia, USA., Naseem S; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA., Beusch CM; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Coskun AF; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA, USA., Abdel-Hakeem MS; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.; Pathology Advanced Translational Research Unit (PATRU), Department of Pathology and 9 Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA., Johnson RP; Division of Microbiology and Immunology, Emory Vaccine Centre, Emory National Primate Research Centre, Emory University, Atlanta, Georgia, USA.; Infectious Disease Division, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Staal FJT; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.; Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Leiden University Medical Center, Netherlands., Velu V; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.; Division of Microbiology and Immunology, Emory Vaccine Centre, Emory National Primate Research Centre, Emory University, Atlanta, Georgia, USA., Paiardini M; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.; Division of Microbiology and Immunology, Emory Vaccine Centre, Emory National Primate Research Centre, Emory University, Atlanta, Georgia, USA., Keele BF; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Silvestri G; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.; Division of Microbiology and Immunology, Emory Vaccine Centre, Emory National Primate Research Centre, Emory University, Atlanta, Georgia, USA., Gordon DE; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA., Tomalka JA; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA., Rahman SA; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.; Division of Microbiology and Immunology, Emory Vaccine Centre, Emory National Primate Research Centre, Emory University, Atlanta, Georgia, USA. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2026 Feb 02. Date of Electronic Publication: 2026 Feb 02. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
